Texas Oncology Paris

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia1 trial
• Ovarian cancer1 trial

Phase

• Phase 2/31 trial
• Phase 41 trial

Status

• Recruiting2 trials

Lead sponsor

• Daiichi Sankyo1 trial
• Eli Lilly and Company1 trial

Running trials

• Recruiting

  A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  NCT07218341· Phase 4· Eli Lilly and Company· Source

  Contact: Harris Naina (principal investigator)

• Recruiting

  A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  NCT06161025· Phase 2/3· Daiichi Sankyo· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic lymphocytic leukaemia1 recruiting
• Ovarian cancer1 recruiting